- Consumer Products
- Latest 70.61
- Currency US$
- Change -2.20
- Percent Change -3.022 %
- Volume 16,840,384
- Wed Dec 11, 2013 04:00 PM EST NASDAQ data delayed 15 minutes.
12 months ended Sep 30, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Oct 29||$0.47||Feb 3||$0.52|
12 months ended Dec 12, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections and bacterial infections, and a specialized focus on cancer. They have expertise in liposomal drug delivery technology, a technology that the company uses to develop drugs that are safer, easier for patients to tolerate and more effective.